Series A
We pull jobs from sources most job seekers never check
About the company
What they build and who they serve.
Fathom Therapeutics, formerly Atommap, is a New York-based drug design company combining quantum chemistry, physics-based simulations, and AI to model protein motion at atomic resolution. Its Microcosmos platform generates the data needed to design small molecules with sharper therapeutic effects and reduced off-target risk. The company runs internal discovery programs and discovery partnerships, with a lead asset advanced into animal efficacy studies.
Why it matters
Signals from funding, traction, and product direction.
- Round was oversubscribed; company rebranded from Atommap Corp. to Fathom Therapeutics alongside the close.
- Mandana Honu, PhD joined as Chief Business Officer; Diala Ezzeddine, PhD joined the board of directors alongside the financing.
- Microcosmos platform simulates protein dynamics at atomic resolution; lead program advanced into animal efficacy studies.
- Microcosmos algorithms accelerate protein dynamics modeling by up to 10,000x without compromising accuracy.
- Founding/leadership team has collectively advanced 19 drugs to the clinic, including seven FDA-approved medicines.
- Microcosmos generated potent, selective novel degraders against an undruggable target within six weeks; candidates now being optimized for clinical development.
Funding history
Rounds and investors over time, newest first.
- $47MSutter Hill Ventures · LeadAlexandria Venture InvestmentsChemistryEmpire State Development's New York Ventures
In the news
Press, announcements, and coverage about this company.
Investors
Focus areas
No open roles on the board yet
We do not have indexed listings for Fathom Therapeutics right now. Roles may still be open on the company site—we will add them here when they appear in our feed.

Don’t get beat to tomorrow’s openings
New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job posts